Traws Pharma
TRAW
TRAW
19 hedge funds and large institutions have $3.98M invested in Traws Pharma in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
61% less capital invested
Capital invested by funds: $10.2M → $3.98M (-$6.26M)
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$759K | |
| 2 | +$593K | |
| 3 | +$230K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$31.1K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$28.9K |
Top Sellers
| 1 | -$161K | |
| 2 | -$147K | |
| 3 | -$89.3K | |
| 4 |
Morgan Stanley
New York
|
-$34.5K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$10.3K |
